Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Deciphering the Epigenetic Landscape in Histiocytic Neoplasms

Mali Salmon-Divon, Refael Meyuchas, Jamal Benhamida, Ofer Shpilberg, Roei D. Mazor, Mariko Yabe, Kseniya Petrova-drus, Omar Abdel-Wahab, Eli L. Diamond, Oshrat Hershkovitz-Rokah

Blood (2023) 142 (Supplement 1): 1161.

https://doi.org/10.1182/blood-2023-185965

Published: 2023

Journal Articles

Outcomes with MEK Inhibitor Therapy Among Adults with Langerhans Cell Histiocytosis (LCH): A Multi-Institutional Study from the Adult LCH Working Group for the Histiocyte Society

Blood (2023) 142 (Supplement 1): 4559.

https://doi.org/10.1182/blood-2023-184911

Published: 2023

Journal Articles

Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

Eli L. Diamond, Benjamin Durham, Ahmet Dogan, Mariko Yabe, Kseniya Petrova-Drus, Raajit K. Rampal, Raajit K. Rampal, Gary Ulaner, Mario Lacouture, Veronica Rotemberg, Anne Covey, Lynn Brody, Omar Abdel-Wahab

Blood (2023) 142 (Supplement 1): 1812.

https://doi.org/10.1182/blood-2023-187508

Published: 2023

Journal Articles

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

Natasha Lewis, Kseniya Petrova-Drus, Rohan Sardana, Qi Gao, Shenon Sethi, Wenbin Xiao, Mikhail Roshal, Jeeyeon Baik, Himanshu Bhurtel, Alison Moskowitz, Steven M. Horwitz, Ahmet Dogan

Blood (2023) 142 (Supplement 1): 849.

https://doi.org/10.1182/blood-2023-187320

Published: 2023

Journal Articles

Acute leukemia with predominantly myeloid differentiation and TBL1XR1 :: CSF1R fusion

Jyoti Kumar, Kseniya Petrova-Drus

Blood (2023) 142 (14): 1253.

https://doi.org/10.1182/blood.2023021632

Published: 2023

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Non-Relapse Mortality in TP53 -Mutated MDS/AML - a Multi-Center Collaborative Study

Blood (2021) 138 (Supplement 1): 2922.

https://doi.org/10.1182/blood-2021-154151

Published: 2021

Journal Articles

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Blood (2019) 134 (Supplement_1): 2148.

https://doi.org/10.1182/blood-2019-125068

Published: 2019

Journal Articles

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence

Blood (2019) 134 (Supplement_1): 3380.

https://doi.org/10.1182/blood-2019-127672

Published: 2019

Journal Articles

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Caleb Ho, MD, Yanming Zhang, MD, Umut Aypar, PhD, Mariko Yabe, MD PhD, Filiz Sen, MD, Maria E Arcila, MD, Ahmet Dogan, MD PhD, Kseniya Petrova-Drus, MD PhD

Blood (2018) 132 (Supplement 1): 3077.

https://doi.org/10.1182/blood-2018-99-115698

Published: 2018

Journal Articles

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection

Caleb Ho, MD, Mustafa Syed, MS, Mikhail Roshal, MD PhD, Kseniya Petrova-Drus, MD PhD, Christine Moung, MD, Jin Juan Yao, MD PhD, Wayne Yu, B.S, Lidia Maciag, Ryma Benayed, PhD, Malin Hultcrantz, MD PhD, Ahmet Dogan, MD PhD, Khedoudja Nafa, PhD, Ola Landgren, MD PhD, Maria E Arcila, MD

Blood (2018) 132 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2018-99-115690

Published: 2018

Journal Articles

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

Abhinita S. Mohanty, MS, Juan Camilo Gomez-Gelvez, MD, Kseniya Petrova-Drus, Michael Zaidinski, Wei Wang, Jin Juan Yao, MD PhD, Caleb Ho, MD, Ahmet Zehir, PhD, Maria E. Arcila

Blood (2017) 130 (Supplement 1): 1943.

https://doi.org/10.1182/blood.V130.Suppl_1.1943.1943

Published: 2017

Journal Articles

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Maria E. Arcila, Mustafa Syed, MS, Wayne Yu, B.S, Hannah Kim, B.S, JinYuan Yao, MD, Caleb Ho, MD, Kseniya Petrova-Drus, Mikhail Roshal, MDPhD, Jae H. Park, MD, Ola Landgren, MD PhD, Ahmet Dogan, MD PhD, Khedoudja Nafa, PhD

Blood (2017) 130 (Supplement 1): 4017.

https://doi.org/10.1182/blood.V130.Suppl_1.4017.4017

Published: 2017

Journal Articles

The apoptotic-cell receptor CR3, but not αvβ5, is a regulator of human dendritic-cell immunostimulatory function

Mojca Škoberne, Selin Somersan, Wanda Almodovar, Tuan Truong, Kseniya Petrova, Peter M. Henson, Nina Bhardwaj

Blood (2006) 108 (3): 947–955.

https://doi.org/10.1182/blood-2005-12-4812

Published: 2006

Includes: Supplemental data

NARROW

Deciphering the Epigenetic Landscape in Histiocytic Neoplasms

Outcomes with MEK Inhibitor Therapy Among Adults with Langerhans Cell Histiocytosis (LCH): A Multi-Institutional Study from the Adult LCH Working Group for the Histiocyte Society

Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

Acute leukemia with predominantly myeloid differentiation and TBL1XR1 :: CSF1R fusion

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Non-Relapse Mortality in TP53 -Mutated MDS/AML - a Multi-Center Collaborative Study

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

The apoptotic-cell receptor CR3, but not αvβ5, is a regulator of human dendritic-cell immunostimulatory function

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only